Regeneron Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
REGN Regeneron Pharmaceuticals Inc
NSC Norfolk Southern Corp
WM Waste Management Inc
ITOS Iteos Therapeutics Inc
CCLD CareCloud Inc
JEF Jefferies Financial Group Inc
RSASF Resaas Services Inc
VRNT Verint Systems Inc
TRHC Tabula Rasa HealthCare Inc
ILMN Illumina Inc
Go

Health Care : Biotechnology | Large Cap Blend
Company profile

Regeneron Pharmaceuticals, Inc. is an integrated biotechnology company that discovers, invents, develops, manufactures, and commercializes medicines for serious diseases. Its commercialized medicines and product candidates in development are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, hematologic conditions, infectious diseases, and rare diseases. Its marketed products include EYLEA (aflibercept) Injection, Dupixent (dupilumab) Injection, Libtayo (cemiplimab) Injection, Praluent (alirocumab) Injection, REGEN-COV, Kevzara (sarilumab) Solution for Subcutaneous Injection, Evkeeza (evinacumab) Injection, Inmazeb (atoltivimab, maftivimab, and odesivimab-ebgn) Injection, ARCALYST (rilonacept) Injection for Subcutaneous Use and ZALTRAP (ziv-aflibercept) Injection for Intravenous Infusion. It also provides Expresse service assurance and CloudCheck WiFi experience management solutions.

Price
Delayed
$772.37
Day's Change
-8.49 (-1.09%)
Bid
--
Ask
--
B/A Size
--
Day's High
778.05
Day's Low
763.15
Volume
(Below Average)

Today's volume of 598,285 shares is on pace to be lower than REGN's 10-day average volume of 724,147 shares.

598,285

OLO ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of November 28, 2022 in the Class Action Filed on Behalf of Olo Inc. Shareholders

5:45 am ET November 22, 2022 (PR Newswire) Print

The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Olo Inc. (NYSE: OLO) alleging that the Company violated federal securities laws.

This lawsuit is on behalf of all persons and entities that purchased shares of Olo's Class A common stock between August 11, 2021 and August 11, 2022.Lead Plaintiff Deadline: November 28, 2022No obligation or cost to you.

Learn more about your recoverable losses in OLO:https://www.kleinstocklaw.com/pslra-1/olo-class-action-loss-submission-form?id=33892&from=4

Olo Inc. NEWS - OLO NEWS

CLASS ACTION CASE DETAILS: The filed complaint alleges that Olo Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) Subway was ending its contract with Olo; (2) Olo's key business metric - active locations - could not continue to grow as defendants touted due to the loss of Subway's business; and (3) as a result of the above, defendants' statements about Olo's business, operations, and prospects were false and misleading and/or lacked a reasonable basis.

WHAT THIS MEANS TO YOU AS A SHAREHOLDER: If you have suffered a loss in Olo you have until November 28, 2022 to petition the court for lead plaintiff status. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

NO COST TO YOU:If you purchased Olo securities during the relevant period, you may be entitled to compensation without payment of any out-of-pocket fees.

HOW TO PROTECT YOUR FINANCIAL INTERESTS: For additional information about the OLO lawsuit, please contact J. Klein, Esq. by telephone at 212-616-4899 or click this link: https://www.kleinstocklaw.com/pslra-1/olo-class-action-loss-submission-form?id=33892&from=4.

ABOUT KLEIN LAW FIRMJ. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. The Klein Law Firm is a boutique litigation firm with experience in a wide range of areas including securities law, corporate finance and commercial litigation. Since 2011, our experienced attorneys have achieved superior results for our clients with a personalized focus. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:J. Klein, Esq.535 Fifth Avenue4th FloorNew York City, NY 10017jk@kleinstocklaw.comTelephone: (212) 616-4899www.kleinstocklaw.com

https://c212.net/c/img/favicon.png?sn=NY44119&sd=2022-11-22

View original content:https://www.prnewswire.com/news-releases/olo-alert-the-klein-law-firm-announces-a-lead-plaintiff-deadline-of-november-28-2022-in-the-class-action-filed-on-behalf-of-olo-inc-shareholders-301684588.html

SOURCE The Klein Law Firm

https://rt.newswire.ca/rt.gif?NewsItemId=NY44119&Transmission_Id=202211220545PR_NEWS_USPR_____NY44119&DateId=20221122

comtex tracking

COMTEX_419473152/1005/2022-11-22T05:45:08

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.